Valuation: Alembic Pharmaceuticals Limited

Market Cap 163B 1.71B 1.48B 1.39B 1.27B 2.39B 2.43B 16.26B 6.38B 81.75B 6.43B 6.29B 272B P/E 2027 *
22.5x
P/E 2028 * 17.3x
Enterprise Value 174B 1.82B 1.58B 1.48B 1.35B 2.54B 2.58B 17.3B 6.79B 86.98B 6.85B 6.7B 290B EV / Sales 2027 *
2.07x
EV / Sales 2028 * 1.79x
Free-Float
29.33%
Yield 2027 *
1.55%
Yield 2028 * 1.83%
1 day+0.15%
1 week+4.30%
Current month+4.30%
1 month+1.77%
3 months+5.63%
6 months+4.45%
Current year-1.75%
1 week 799.1
Extreme 799.1
855.9
1 month 787.4
Extreme 787.4
855.9
Current year 635.8
Extreme 635.8
855.9
1 year 635.8
Extreme 635.8
1,002
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 07/07/2025
Chief Tech/Sci/R&D Officer - 01/07/2023
Chief Operating Officer - 21/07/2025
Director TitleAgeSince
Chairman 78 08/06/2012
Director/Board Member 50 01/01/2007
Director/Board Member 66 18/01/2003
Date Insider Type Main position Quantity % Market Cap.
28/03/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
24/03/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
21/03/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%+4.30%-11.20%+5.74% 1.71B
+2.38%+8.11%+90.85%+132.54% 1,057B
+0.70%+2.04%+49.36%+50.79% 625B
-0.03%-0.31%+23.01%+61.35% 435B
+1.58%+4.80%+51.48%+39.79% 363B
+0.65%+1.85%+32.06%+39.99% 296B
+0.79%+4.26%+8.64%+7.42% 249B
+0.70%+8.73%+44.49%+57.19% 222B
+0.34%+1.27%-5.10%-50.94% 209B
+0.33%+1.55%+10.55%+66.48% 165B
Average +0.67%+1.26%+29.41%+41.03% 362.25B
Weighted average by Cap. +1.04%+1.33%+49.07%+66.17%

Financials

2027 *2028 *
Net sales 84.17B 883M 764M 714M 653M 1.23B 1.25B 8.37B 3.29B 42.11B 3.31B 3.24B 140B 92.45B 969M 839M 784M 717M 1.35B 1.37B 9.2B 3.61B 46.25B 3.64B 3.56B 154B
Net income 7.32B 76.74M 66.44M 62.1M 56.75M 107M 109M 728M 286M 3.66B 288M 282M 12.2B 9.48B 99.36M 86.02M 80.4M 73.48M 138M 141M 943M 370M 4.74B 373M 365M 15.79B
Net Debt 10.45B 110M 94.86M 88.66M 81.03M 153M 155M 1.04B 408M 5.23B 411M 402M 17.41B 1.91B 20.08M 17.38M 16.25M 14.85M 27.98M 28.42M 191M 74.75M 958M 75.39M 73.74M 3.19B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
10/08/26 831.35 +0.15% 83,817
07/08/26 ₹830.10 -0.52% 156,108
06/08/26 ₹834.45 +1.99% 210,314
05/08/26 ₹818.20 +1.09% 243,621
04/08/26 ₹809.40 +0.45% 485,095
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
830.10INR
Average target price
949.30INR
Spread / Average Target
+14.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock